Oxford University researchers on Tuesday paused a trial of the jointly developed AstraZeneca COVID-19 vaccine in children as Britain's medical regulator reviews rare instances of blood clots in adults. The trial in children as young as 6 years old was put on hold while Britain's Medicines and Healthcare products Regulatory Agency, or MHRA, reviews rare cases of people experiencing blood clots while simultaneously having low levels of blood platelets, a ...